Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Issue Cover for Volume 29, Number 10—October 2023

Volume 29, Number 10—October 2023

[PDF - 9.82 MB - 242 pages]

Synopses

Medscape CME Activity
Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022 [PDF - 3.00 MB - 12 pages]
C. Hyams et al.

Ongoing surveillance after pneumococcal conjugate vaccination (PCV) deployment is essential to inform policy decisions and monitor serotype replacement. We report serotype and disease severity trends in 3,719 adults hospitalized for pneumococcal disease in Bristol and Bath, United Kingdom, during 2006–2022. Of those cases, 1,686 were invasive pneumococcal disease (IPD); 1,501 (89.0%) had a known serotype. IPD decreased during the early COVID-19 pandemic but during 2022 gradually returned to prepandemic levels. Disease severity changed throughout this period: CURB65 severity scores and inpatient deaths decreased and ICU admissions increased. PCV7 and PCV13 serotype IPD decreased from 2006–2009 to 2021–2022. However, residual PCV13 serotype IPD remained, representing 21.7% of 2021–2022 cases, indicating that major adult PCV serotype disease still occurs despite 17 years of pediatric PCV use. Percentages of serotype 3 and 8 IPD increased, and 19F and 19A reemerged. In 2020–2022, a total of 68.2% IPD cases were potentially covered by PCV20.

EID Hyams C, Challen R, Hettle D, Amin-Chowdhury Z, Grimes C, Ruffino G, et al. Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022. Emerg Infect Dis. 2023;29(10):1953-1964. https://doi.org/10.3201/eid2910.230519
AMA Hyams C, Challen R, Hettle D, et al. Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022. Emerging Infectious Diseases. 2023;29(10):1953-1964. doi:10.3201/eid2910.230519.
APA Hyams, C., Challen, R., Hettle, D., Amin-Chowdhury, Z., Grimes, C., Ruffino, G....Finn, A. (2023). Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022. Emerging Infectious Diseases, 29(10), 1953-1964. https://doi.org/10.3201/eid2910.230519.

Medscape CME Activity
Spike in Congenital Syphilis, Mississippi, USA, 2016–2022 [PDF - 1.31 MB - 8 pages]
M. Staneva et al.

In Mississippi, USA, infant hospitalization with congenital syphilis (CS) spiked by 1,000%, from 10 in 2016 to 110 in 2022. To determine the causes of this alarming development, we analyzed Mississippi hospital discharge data to evaluate trends, demographics, outcomes, and risk factors for infants diagnosed with CS hospitalized during 2016–2022. Of the 367 infants hospitalized with a CS diagnosis, 97.6% were newborn, 92.6% were covered by Medicaid, 71.1% were African American, and 58.0% were nonurban residents. Newborns with CS had higher odds of being affected by maternal illicit drug use, being born prematurely (<37 weeks), and having very low birthweight (<1,500 g) than those without CS. Mean length of hospital stay (14.5 days vs. 3.8 days) and mean charges ($56,802 vs. $13,945) were also higher for infants with CS than for those without. To address escalation of CS, Mississippi should invest in comprehensive prenatal care and early treatment of vulnerable populations.

EID Staneva M, Hobbs CV, Dobbs T. Spike in Congenital Syphilis, Mississippi, USA, 2016–2022. Emerg Infect Dis. 2023;29(10):1965-1972. https://doi.org/10.3201/eid2910.230421
AMA Staneva M, Hobbs CV, Dobbs T. Spike in Congenital Syphilis, Mississippi, USA, 2016–2022. Emerging Infectious Diseases. 2023;29(10):1965-1972. doi:10.3201/eid2910.230421.
APA Staneva, M., Hobbs, C. V., & Dobbs, T. (2023). Spike in Congenital Syphilis, Mississippi, USA, 2016–2022. Emerging Infectious Diseases, 29(10), 1965-1972. https://doi.org/10.3201/eid2910.230421.

Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022 [PDF - 779 KB - 6 pages]
J. Lee et al.

Controlling the spread of carbapenem-resistant Enterobacterales is a global priority. Using National Healthcare Safety Network data, we characterized the changing epidemiology of carbapenem-resistant Klebsiella pneumoniae (CRKP) in a large public health system in New York, New York, USA. During 2016–2020, CRKP cases declined; however, during 2021–June 2022, a notable increase occurred. Of 509 cases, 262 (51%) were considered community-onset, including 149 in patients who were living at home. Of 182 isolates with proven or presumptive (ceftazidime/avibactam susceptible) enzymes, 143 were serine carbapenemases; most confirmed cases were K. pneumoniae carbapenemase. The remaining 39 cases were proven or presumptive metallo-β-lactamases; all confirmed cases were New Delhi metallo-β-lactamases. After 2020, a marked increase occurred in the percentage of isolates possessing metallo-β-lactamases. Most patients with metallo-β-lactamases originated from long-term care facilities. An aggressive and universal program involving surveillance and isolation will be needed to control the spread of CRKP in the city of New York.

EID Lee J, Sunny S, Nazarian E, Fornek M, Abdallah M, Episcopia B, et al. Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022. Emerg Infect Dis. 2023;29(10):1973-1978. https://doi.org/10.3201/eid2910.230153
AMA Lee J, Sunny S, Nazarian E, et al. Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022. Emerging Infectious Diseases. 2023;29(10):1973-1978. doi:10.3201/eid2910.230153.
APA Lee, J., Sunny, S., Nazarian, E., Fornek, M., Abdallah, M., Episcopia, B....Quale, J. (2023). Carbapenem-Resistant Klebsiella pneumoniae in Large Public Acute-Care Healthcare System, New York, New York, USA, 2016–2022. Emerging Infectious Diseases, 29(10), 1973-1978. https://doi.org/10.3201/eid2910.230153.
Research

Posttransfusion Sepsis Attributable to Bacterial Contamination in Platelet Collection Set Manufacturing Facility, United States [PDF - 3.44 MB - 11 pages]
I. Kracalik et al.

During May 2018‒December 2022, we reviewed transfusion-transmitted sepsis cases in the United States attributable to polymicrobial contaminated apheresis platelet components, including Acinetobacter calcoaceticus‒baumannii complex or Staphylococcus saprophyticus isolated from patients and components. Transfused platelet components underwent bacterial risk control strategies (primary culture, pathogen reduction or primary culture, and secondary rapid test) before transfusion. Environmental samples were collected from a platelet collection set manufacturing facility. Seven sepsis cases from 6 platelet donations from 6 different donors were identified in patients from 6 states; 3 patients died. Cultures identified Acinetobacter calcoaceticus‒baumannii complex in 6 patients and 6 transfused platelets, S. saprophyticus in 4 patients and 4 transfused platelets. Whole-genome sequencing showed environmental isolates from the manufacturer were closely related genetically to patient and platelet isolates, indicating the manufacturer was the most probable source of recurrent polymicrobial contamination. Clinicians should maintain awareness of possible transfusion-transmitted sepsis even when using bacterial risk control strategies.

EID Kracalik I, Kent AG, Villa CH, Gable P, Annambhotla P, McAllister G, et al. Posttransfusion Sepsis Attributable to Bacterial Contamination in Platelet Collection Set Manufacturing Facility, United States. Emerg Infect Dis. 2023;29(10):1979-1989. https://doi.org/10.3201/eid2910.230869
AMA Kracalik I, Kent AG, Villa CH, et al. Posttransfusion Sepsis Attributable to Bacterial Contamination in Platelet Collection Set Manufacturing Facility, United States. Emerging Infectious Diseases. 2023;29(10):1979-1989. doi:10.3201/eid2910.230869.
APA Kracalik, I., Kent, A. G., Villa, C. H., Gable, P., Annambhotla, P., McAllister, G....Basavaraju, S. V. (2023). Posttransfusion Sepsis Attributable to Bacterial Contamination in Platelet Collection Set Manufacturing Facility, United States. Emerging Infectious Diseases, 29(10), 1979-1989. https://doi.org/10.3201/eid2910.230869.

Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi [PDF - 1.32 MB - 9 pages]
L. Mndala et al.

We used national facility-level data from all government hospitals in Malawi to examine the effects of the second and third COVID-19 waves on maternal and neonatal outcomes and access to care during September 6, 2020–October 31, 2021. The COVID-19 pandemic affected maternal and neonatal health not only through direct infections but also through disruption of the health system, which could have wider indirect effects on critical maternal and neonatal outcomes. In an interrupted time series analysis, we noted a cumulative 15.4% relative increase (63 more deaths) in maternal deaths than anticipated across the 2 COVID-19 waves. We observed a 41% decrease in postnatal care visits at the onset of the second COVID-19 wave and 0.2% by the third wave, cumulative to 36,809 fewer visits than anticipated. Our findings demonstrate the need for strengthening health systems, particularly in resource-constrained settings, to prepare for future pandemic threats.

EID Mndala L, Chapuma C, Riches J, Gadama L, Kachale F, Bilesi R, et al. Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi. Emerg Infect Dis. 2023;29(10):1990-1998. https://doi.org/10.3201/eid2910.230003
AMA Mndala L, Chapuma C, Riches J, et al. Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi. Emerging Infectious Diseases. 2023;29(10):1990-1998. doi:10.3201/eid2910.230003.
APA Mndala, L., Chapuma, C., Riches, J., Gadama, L., Kachale, F., Bilesi, R....Lissauer, D. (2023). Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi. Emerging Infectious Diseases, 29(10), 1990-1998. https://doi.org/10.3201/eid2910.230003.

Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada [PDF - 1.71 MB - 9 pages]
Y. Chan et al.

In British Columbia, Canada, initial growth of the SARS-CoV-2 Delta variant was slower than that reported in other jurisdictions. Delta became the dominant variant (>50% prevalence) within ≈7–13 weeks of first detection in regions within the United Kingdom and United States. In British Columbia, it remained at <10% of weekly incident COVID-19 cases for 13 weeks after first detection on March 21, 2021, eventually reaching dominance after 17 weeks. We describe the growth of Delta variant cases in British Columbia during March 1–June 30, 2021, and apply retrospective counterfactual modeling to examine factors for the initially low COVID-19 case rate after Delta introduction, such as vaccination coverage and nonpharmaceutical interventions. Growth of COVID-19 cases in the first 3 months after Delta emergence was likely limited in British Columbia because additional nonpharmaceutical interventions were implemented to reduce levels of contact at the end of March 2021, soon after variant emergence.

EID Chan Y, Irvine MA, Prystajecky N, Sbihi H, Taylor M, Joffres Y, et al. Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada. Emerg Infect Dis. 2023;29(10):1999-2007. https://doi.org/10.3201/eid2910.230055
AMA Chan Y, Irvine MA, Prystajecky N, et al. Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada. Emerging Infectious Diseases. 2023;29(10):1999-2007. doi:10.3201/eid2910.230055.
APA Chan, Y., Irvine, M. A., Prystajecky, N., Sbihi, H., Taylor, M., Joffres, Y....Galanis, E. (2023). Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada. Emerging Infectious Diseases, 29(10), 1999-2007. https://doi.org/10.3201/eid2910.230055.

Community Outbreak of Pseudomonas aeruginosa Infections Associated with Contaminated Piercing Aftercare Solution, Australia, 2021 [PDF - 1.49 MB - 8 pages]
B. T. Trevitt et al.

In April 2021, the South Eastern Sydney Local Health District Public Health Unit (Sydney, New South Wales, Australia) was notified of 3 patients with Pseudomonas aeruginosa infections secondary to skin piercings performed at the same salon. Active case finding through laboratories, clinician alerts, and monitoring hospital visits for piercing-related infections identified additional cases across New South Wales, and consumers were alerted. We identified 13 confirmed and 40 probable case-patients and linked clinical isolates by genomic sequencing. Ten confirmed case-patients had used the same brand and batch of aftercare solution. We isolated P. aeruginosa from opened and unopened bottles of this solution batch that matched the outbreak strain identified by genomic sequencing. Piercing-related infections returned to baseline levels after this solution batch was recalled. Early outbreak detection and source attribution via genomic sequencing are crucial for controlling outbreaks linked to contaminated products. Manufacturing standards for nonsterile cosmetic products and guidance for piercing aftercare warrant review.

EID Trevitt BT, Katelaris AL, Bateman-Steel C, Chaverot S, Flanigan S, Cains T, et al. Community Outbreak of Pseudomonas aeruginosa Infections Associated with Contaminated Piercing Aftercare Solution, Australia, 2021. Emerg Infect Dis. 2023;29(10):2008-2015. https://doi.org/10.3201/eid2910.230560
AMA Trevitt BT, Katelaris AL, Bateman-Steel C, et al. Community Outbreak of Pseudomonas aeruginosa Infections Associated with Contaminated Piercing Aftercare Solution, Australia, 2021. Emerging Infectious Diseases. 2023;29(10):2008-2015. doi:10.3201/eid2910.230560.
APA Trevitt, B. T., Katelaris, A. L., Bateman-Steel, C., Chaverot, S., Flanigan, S., Cains, T....Sheppeard, V. (2023). Community Outbreak of Pseudomonas aeruginosa Infections Associated with Contaminated Piercing Aftercare Solution, Australia, 2021. Emerging Infectious Diseases, 29(10), 2008-2015. https://doi.org/10.3201/eid2910.230560.

Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States [PDF - 726 KB - 8 pages]
S. A. Nabity et al.

Little is known about co-occurring tuberculosis (TB) and COVID-19 in low TB incidence settings. We obtained a cross-section of 333 persons in the United States co-diagnosed with TB and COVID-19 within 180 days and compared them to 4,433 persons with TB only in 2020 and 18,898 persons with TB during 2017‒2019. Across both comparison groups, a higher proportion of persons with TB–COVID-19 were Hispanic, were long-term care facility residents, and had diabetes. When adjusted for age, underlying conditions, and TB severity, COVID-19 co-infection was not statistically associated with death compared with TB infection only in 2020 (adjusted prevalence ratio 1.0 [95% CI 0.8‒1.4]). Among TB–COVID-19 patients, death was associated with a shorter interval between TB and COVID-19 diagnoses, older age, and being immunocompromised (non-HIV). TB–COVID-19 deaths in the United States appear to be concentrated in subgroups sharing characteristics known to increase risk for death from either disease alone.

EID Nabity SA, Marks SM, Goswami ND, Smith SR, Timme E, Price SF, et al. Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States. Emerg Infect Dis. 2023;29(10):2016-2023. https://doi.org/10.3201/eid2910.230286
AMA Nabity SA, Marks SM, Goswami ND, et al. Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States. Emerging Infectious Diseases. 2023;29(10):2016-2023. doi:10.3201/eid2910.230286.
APA Nabity, S. A., Marks, S. M., Goswami, N. D., Smith, S. R., Timme, E., Price, S. F....Wang, S. (2023). Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States. Emerging Infectious Diseases, 29(10), 2016-2023. https://doi.org/10.3201/eid2910.230286.

Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022 [PDF - 1.43 MB - 8 pages]
R. E. Harrison et al.

Early detection of increased infections or new variants of SARS-CoV-2 is critical for public health response. To determine whether cycle threshold (Ct) data from PCR tests for SARS-CoV-2 could serve as an early indicator of epidemic growth, we analyzed daily mean Ct values in England, UK, by gene target and used iterative sequential regression to detect break points in mean Ct values (and positive test counts). To monitor the epidemic in England, we continued those analyses in real time. During September 2020–January 2022, a total of 7,611,153 positive SARS-CoV-2 PCR test results with Ct data were reported. Spike (S) gene target (S+/S−)–specific mean Ct values decreased 6–29 days before positive test counts increased, and S-gene Ct values provided early indication of increasing new variants (Delta and Omicron). Our approach was beneficial in the context of the first waves of the COVID-19 pandemic and can be used to support future infectious disease monitoring.

EID Harrison RE, Hamada A, Haswell N, Groves A, Vihta K, Cella K, et al. Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022. Emerg Infect Dis. 2023;29(10):2024-2031. https://doi.org/10.3201/eid2910.230030
AMA Harrison RE, Hamada A, Haswell N, et al. Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022. Emerging Infectious Diseases. 2023;29(10):2024-2031. doi:10.3201/eid2910.230030.
APA Harrison, R. E., Hamada, A., Haswell, N., Groves, A., Vihta, K., Cella, K....Seale, A. C. (2023). Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020–2022. Emerging Infectious Diseases, 29(10), 2024-2031. https://doi.org/10.3201/eid2910.230030.

Comprehensive Case–Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia [PDF - 4.83 MB - 12 pages]
B. J. McNamara et al.

To examine protective and risk factors for Buruli ulcer (BU), we conducted a case–control study of 245 adult BU cases and 481 postcode-matched controls across BU-endemic areas of Victoria, Australia. We calculated age- and sex-adjusted odds ratios for socio-environmental, host, and behavioral factors associated with BU by using conditional logistic regression. Odds of BU were >2-fold for persons with diabetes mellitus and persons working outdoors who had soil contact in BU-endemic areas (compared with indoor work) but were lower among persons who had bacillus Calmette–Guérin vaccinations. BU was associated with increasing numbers of possums and with ponds and bore water use at residences. Using insect repellent, covering arms and legs outdoors, and immediately washing wounds were protective; undertaking multiple protective behaviors was associated with the lowest odds of BU. Skin hygiene/protection behaviors and previous bacillus Calmette–Guérin vaccination might provide protection against BU in BU-endemic areas.

EID McNamara BJ, Blasdell KR, Yerramilli A, Smith IL, Clayton SL, Dunn M, et al. Comprehensive Case–Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia. Emerg Infect Dis. 2023;29(10):2032-2043. https://doi.org/10.3201/eid2910.230011
AMA McNamara BJ, Blasdell KR, Yerramilli A, et al. Comprehensive Case–Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia. Emerging Infectious Diseases. 2023;29(10):2032-2043. doi:10.3201/eid2910.230011.
APA McNamara, B. J., Blasdell, K. R., Yerramilli, A., Smith, I. L., Clayton, S. L., Dunn, M....Athan, E. (2023). Comprehensive Case–Control Study of Protective and Risk Factors for Buruli Ulcer, Southeastern Australia. Emerging Infectious Diseases, 29(10), 2032-2043. https://doi.org/10.3201/eid2910.230011.

Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa [PDF - 2.39 MB - 10 pages]
D. Kekana et al.

Candida auris was first detected at a university-affiliated hospital in Johannesburg, South Africa, in 2009. We used whole-genome sequencing to describe the molecular epidemiology of C. auris in the same hospital during 2016–2020; the neonatal unit had a persistent outbreak beginning in June 2019. Of 287 cases with culture-confirmed C. auris infection identified through laboratory surveillance, 207 (72%) had viable isolates and 188 (66%) were processed for whole-genome sequencing. Clade III (118/188, 63%) and IV (70/188, 37%) isolates co-circulated in the hospital. All 181/188 isolates that had a fluconazole MIC >32 µg/mL had ERG11 mutations; clade III isolates had VF125AL substitutions, and clade IV isolates had K177R/N335S/E343D substitutions. Dominated by clade III, the neonatal unit outbreak accounted for 32% (91/287) of all cases during the study period. The outbreak may have originated through transmission from infected or colonized patients, colonized healthcare workers, or contaminated equipment/environment.

EID Kekana D, Naicker SD, Shuping L, Velaphi S, Nakwa FL, Wadula J, et al. Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa. Emerg Infect Dis. 2023;29(10):2044-2053. https://doi.org/10.3201/eid2910.230181
AMA Kekana D, Naicker SD, Shuping L, et al. Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa. Emerging Infectious Diseases. 2023;29(10):2044-2053. doi:10.3201/eid2910.230181.
APA Kekana, D., Naicker, S. D., Shuping, L., Velaphi, S., Nakwa, F. L., Wadula, J....Govender, N. P. (2023). Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa. Emerging Infectious Diseases, 29(10), 2044-2053. https://doi.org/10.3201/eid2910.230181.

Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021 [PDF - 4.23 MB - 11 pages]
G. Jones et al.

Shiga toxin–producing Escherichia coli–associated pediatric hemolytic uremic syndrome (STEC-HUS) remains an important public health risk in France. Cases are primarily sporadic, and geographic heterogeneity has been observed in crude incidence rates. We conducted a retrospective study of 1,255 sporadic pediatric STEC-HUS cases reported during 2012–2021 to describe spatiotemporal dynamics and geographic patterns of higher STEC-HUS risk. Annual case notifications ranged from 109 to 163. Most cases (n = 780 [62%]) were in children <3 years of age. STEC serogroups O26, O80, and O157 accounted for 78% (559/717) of cases with serogroup data. We identified 13 significant space-time clusters and 3 major geographic zones of interest; areas of southeastern France were included in >5 annual space-time clusters. The results of this study have numerous implications for outbreak detection and investigation and research perspectives to improve knowledge of environmental risk factors associated with geographic disparities in STEC-HUS in France.

EID Jones G, Mariani-Kurkdjian P, Cointe A, Bonacorsi S, Lefèvre S, Weill F, et al. Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021. Emerg Infect Dis. 2023;29(10):2054-2064. https://doi.org/10.3201/eid2910.230382
AMA Jones G, Mariani-Kurkdjian P, Cointe A, et al. Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021. Emerging Infectious Diseases. 2023;29(10):2054-2064. doi:10.3201/eid2910.230382.
APA Jones, G., Mariani-Kurkdjian, P., Cointe, A., Bonacorsi, S., Lefèvre, S., Weill, F....Le Strat, Y. (2023). Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021. Emerging Infectious Diseases, 29(10), 2054-2064. https://doi.org/10.3201/eid2910.230382.

Stability of Monkeypox Virus in Body Fluids and Wastewater [PDF - 1.82 MB - 8 pages]
C. Yinda et al.

An outbreak of human mpox infection in nonendemic countries appears to have been driven largely by transmission through body fluids or skin-to-skin contact during sexual activity. We evaluated the stability of monkeypox virus (MPXV) in different environments and specific body fluids and tested the effectiveness of decontamination methodologies. MPXV decayed faster at higher temperatures, and rates varied considerably depending on the medium in which virus was suspended, both in solution and on surfaces. More proteinaceous fluids supported greater persistence. Chlorination was an effective decontamination technique, but only at higher concentrations. Wastewater was more difficult to decontaminate than plain deionized water; testing for infectious MPXV could be a helpful addition to PCR-based wastewater surveillance when high levels of viral DNA are detected. Our findings suggest that, because virus stability is sufficient to support environmental MPXV transmission in healthcare settings, exposure and dose-response will be limiting factors for those transmission routes.

EID Yinda C, Morris DH, Fischer RJ, Gallogly S, Weishampel ZA, Port JR, et al. Stability of Monkeypox Virus in Body Fluids and Wastewater. Emerg Infect Dis. 2023;29(10):2065-2072. https://doi.org/10.3201/eid2910.230824
AMA Yinda C, Morris DH, Fischer RJ, et al. Stability of Monkeypox Virus in Body Fluids and Wastewater. Emerging Infectious Diseases. 2023;29(10):2065-2072. doi:10.3201/eid2910.230824.
APA Yinda, C., Morris, D. H., Fischer, R. J., Gallogly, S., Weishampel, Z. A., Port, J. R....Munster, V. J. (2023). Stability of Monkeypox Virus in Body Fluids and Wastewater. Emerging Infectious Diseases, 29(10), 2065-2072. https://doi.org/10.3201/eid2910.230824.

Ancestral Origin and Dissemination Dynamics of Reemerging Toxigenic Vibrio cholerae, Haiti [PDF - 3.21 MB - 10 pages]
C. N. Mavian et al.

The 2010 cholera epidemic in Haiti was thought to have ended in 2019, and the Prime Minister of Haiti declared the country cholera-free in February 2022. On September 25, 2022, cholera cases were again identified in Port-au-Prince. We compared genomic data from 42 clinical Vibrio cholerae strains from 2022 with data from 327 other strains from Haiti and 1,824 strains collected worldwide. The 2022 isolates were homogeneous and closely related to clinical and environmental strains circulating in Haiti during 2012–2019. Bayesian hypothesis testing indicated that the 2022 clinical isolates shared their most recent common ancestor with an environmental lineage circulating in Haiti in July 2018. Our findings strongly suggest that toxigenic V. cholerae O1 can persist for years in aquatic environmental reservoirs and ignite new outbreaks. These results highlight the urgent need for improved public health infrastructure and possible periodic vaccination campaigns to maintain population immunity against V. cholerae.

EID Mavian CN, Tagliamonte MS, Alam MT, Sakib S, Cash MN, Moir M, et al. Ancestral Origin and Dissemination Dynamics of Reemerging Toxigenic Vibrio cholerae, Haiti. Emerg Infect Dis. 2023;29(10):2072-2082. https://doi.org/10.3201/eid2910.230554
AMA Mavian CN, Tagliamonte MS, Alam MT, et al. Ancestral Origin and Dissemination Dynamics of Reemerging Toxigenic Vibrio cholerae, Haiti. Emerging Infectious Diseases. 2023;29(10):2072-2082. doi:10.3201/eid2910.230554.
APA Mavian, C. N., Tagliamonte, M. S., Alam, M. T., Sakib, S., Cash, M. N., Moir, M....Ali, A. (2023). Ancestral Origin and Dissemination Dynamics of Reemerging Toxigenic Vibrio cholerae, Haiti. Emerging Infectious Diseases, 29(10), 2072-2082. https://doi.org/10.3201/eid2910.230554.

Treponema pallidum Detection at Asymptomatic Oral, Anal, and Vaginal Sites in Adults Reporting Sexual Contact with Persons with Syphilis [PDF - 1.06 MB - 10 pages]
E. T. Aung et al.

We investigated Treponema pallidum PCR positivity at mucosal sites (oral, anal, and vaginal sites) among adults who had sexual contact with a person with syphilis (syphilis contacts). All syphilis contacts had oral rinse and swab samples collected for testing. Men who have sex with men had anal swab and women had vaginal swab samples collected for testing, regardless of the presence of lesions. Of 407 persons tested, 42 (10%) had early syphilis diagnosed; of those, 19 (45%) tested positive by PCR from any anatomic site and had a positive serologic test. T. pallidum was positive from vaginal samples in 3 women, anal samples in 3 men, and oral cavity samples in 2 women and 3 men, without symptoms at those sites. Three women had no prior syphilis serologic test. T. pallidum detection at asymptomatic mucosal sites suggests early syphilis infections, particularly in cases that would conventionally be staged as latent syphilis of unknown duration.

EID Aung ET, Fairley CK, Williamson DA, Azzato F, Towns JM, Wigan R, et al. Treponema pallidum Detection at Asymptomatic Oral, Anal, and Vaginal Sites in Adults Reporting Sexual Contact with Persons with Syphilis. Emerg Infect Dis. 2023;29(10):2083-2092. https://doi.org/10.3201/eid2910.230660
AMA Aung ET, Fairley CK, Williamson DA, et al. Treponema pallidum Detection at Asymptomatic Oral, Anal, and Vaginal Sites in Adults Reporting Sexual Contact with Persons with Syphilis. Emerging Infectious Diseases. 2023;29(10):2083-2092. doi:10.3201/eid2910.230660.
APA Aung, E. T., Fairley, C. K., Williamson, D. A., Azzato, F., Towns, J. M., Wigan, R....Chen, M. Y. (2023). Treponema pallidum Detection at Asymptomatic Oral, Anal, and Vaginal Sites in Adults Reporting Sexual Contact with Persons with Syphilis. Emerging Infectious Diseases, 29(10), 2083-2092. https://doi.org/10.3201/eid2910.230660.
Policy Review

Managing Risk for Congenital Syphilis, Perth, Western Australia, Australia [PDF - 644 KB - 9 pages]
H. MacKenzie et al.

The recent resurgence of infectious syphilis across many high-income countries has been accompanied by a shift in demographics, including infections increasing among women of reproductive age. Consequently, several high-income countries are reporting increasing cases of congenital syphilis, a disease associated with a range of health and social consequences and a disease that is treatable, is preventable, and could be eliminated. To prevent congenital syphilis in the large cosmopolitan city of Perth, Western Australia, Australia, multilevel coordinated action was undertaken, including increased frequency of syphilis screening of pregnant women, workforce education and community engagement, regular interagency meetings to manage syphilis during pregnancy, use of a dynamic electronic syphilis register, use of synoptic (structured) reporting to guide management at delivery (neonatal management plans), and congenital syphilis case reviews. Other jurisdictions facing increasing syphilis cases should consider adopting these measures to reduce the risk for congenital syphilis.

EID MacKenzie H, McEvoy SP, Ford TJ. Managing Risk for Congenital Syphilis, Perth, Western Australia, Australia. Emerg Infect Dis. 2023;29(10):2093-2101. https://doi.org/10.3201/eid2910.230432
AMA MacKenzie H, McEvoy SP, Ford TJ. Managing Risk for Congenital Syphilis, Perth, Western Australia, Australia. Emerging Infectious Diseases. 2023;29(10):2093-2101. doi:10.3201/eid2910.230432.
APA MacKenzie, H., McEvoy, S. P., & Ford, T. J. (2023). Managing Risk for Congenital Syphilis, Perth, Western Australia, Australia. Emerging Infectious Diseases, 29(10), 2093-2101. https://doi.org/10.3201/eid2910.230432.
Dispatches

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States [PDF - 279 KB - 3 pages]
C. A. Winston et al.

We estimated direct costs of a 4-month or 6-month regimen for drug-susceptible pulmonary tuberculosis treatment in the United States. Costs were $23,000 per person treated. Actual treatment costs will vary depending on examination and medication charges, as well as expenses associated with directly observed therapy.

EID Winston CA, Marks SM, Carr W. Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States. Emerg Infect Dis. 2023;29(10):2102-2104. https://doi.org/10.3201/eid2910.230314
AMA Winston CA, Marks SM, Carr W. Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States. Emerging Infectious Diseases. 2023;29(10):2102-2104. doi:10.3201/eid2910.230314.
APA Winston, C. A., Marks, S. M., & Carr, W. (2023). Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States. Emerging Infectious Diseases, 29(10), 2102-2104. https://doi.org/10.3201/eid2910.230314.

Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria [PDF - 1.58 MB - 3 pages]
M. Seles et al.

A previously healthy man in Austria had tularemia epididymo-orchitis develop, leading to unilateral orchiectomy. Francisella tularensis subspecies holartica was detected by 16S rRNA gene sequencing analysis of inflamed granulomatous testicular tissue. Clinicians should suspect F. tularensis as a rare etiologic microorganism in epididymo-orchitis patients with relevant risk factors.

EID Seles M, Altziebler J, Gorkiewicz G, Kriegl L, Hatzl S, Ahyai S, et al. Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria. Emerg Infect Dis. 2023;29(10):2105-2107. https://doi.org/10.3201/eid2910.230436
AMA Seles M, Altziebler J, Gorkiewicz G, et al. Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria. Emerging Infectious Diseases. 2023;29(10):2105-2107. doi:10.3201/eid2910.230436.
APA Seles, M., Altziebler, J., Gorkiewicz, G., Kriegl, L., Hatzl, S., Ahyai, S....Krause, R. (2023). Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria. Emerging Infectious Diseases, 29(10), 2105-2107. https://doi.org/10.3201/eid2910.230436.

Listeria monocytogenes Transmission from Donated Blood to Platelet Transfusion Recipient, Italy [PDF - 631 KB - 4 pages]
M. Gori et al.

We report Listeria monocytogenes infection in a patient in Italy who was transfused with pooled platelet concentrate. Genomic analysis revealed that L. monocytogenes isolates from the donor blood unit, the transfused platelets, and the patient’s blood culture were genetically closely related, confirming transfusion transmission. Additional surveillance and secondary bacterial screening could improve transfusion safety.

EID Gori M, Bolzoni L, Scaltriti E, Andriani L, Marano V, Morabito F, et al. Listeria monocytogenes Transmission from Donated Blood to Platelet Transfusion Recipient, Italy. Emerg Infect Dis. 2023;29(10):2108-21011. https://doi.org/10.3201/eid2910.230746
AMA Gori M, Bolzoni L, Scaltriti E, et al. Listeria monocytogenes Transmission from Donated Blood to Platelet Transfusion Recipient, Italy. Emerging Infectious Diseases. 2023;29(10):2108-21011. doi:10.3201/eid2910.230746.
APA Gori, M., Bolzoni, L., Scaltriti, E., Andriani, L., Marano, V., Morabito, F....Tanzi, E. (2023). Listeria monocytogenes Transmission from Donated Blood to Platelet Transfusion Recipient, Italy. Emerging Infectious Diseases, 29(10), 2108-21011. https://doi.org/10.3201/eid2910.230746.

Imported Toxigenic Corynebacterium Diphtheriae in Refugees with Polymicrobial Skin Infections, Germany, 2022 [PDF - 1.30 MB - 4 pages]
B. Spielberger et al.

During August–December 2022, toxigenic Corynebacterium diphtheriae was isolated from 25 refugees with skin infections and 2 refugees with asymptomatic throat colonization at a refugee reception center in Germany. None had systemic toxin-mediated illness. Of erosive/ulcerative skin infections, 96% were polymicrobial. Erosive/ulcerative wounds in refugees should undergo testing to rule out cutaneous diphtheria.

EID Spielberger B, Hansel A, Nazary A, Kleißle E, Lehr C, Utz M, et al. Imported Toxigenic Corynebacterium Diphtheriae in Refugees with Polymicrobial Skin Infections, Germany, 2022. Emerg Infect Dis. 2023;29(10):2112-2115. https://doi.org/10.3201/eid2910.230285
AMA Spielberger B, Hansel A, Nazary A, et al. Imported Toxigenic Corynebacterium Diphtheriae in Refugees with Polymicrobial Skin Infections, Germany, 2022. Emerging Infectious Diseases. 2023;29(10):2112-2115. doi:10.3201/eid2910.230285.
APA Spielberger, B., Hansel, A., Nazary, A., Kleißle, E., Lehr, C., Utz, M....Kern, W. V. (2023). Imported Toxigenic Corynebacterium Diphtheriae in Refugees with Polymicrobial Skin Infections, Germany, 2022. Emerging Infectious Diseases, 29(10), 2112-2115. https://doi.org/10.3201/eid2910.230285.

Expansion of Invasive Group A Streptococcus M1UK Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021 [PDF - 1.46 MB - 5 pages]
Y. Li et al.

From 2015–2018 to 2019‒2021, hypertoxigenic M1UK lineage among invasive group A Streptococcus increased in the United States (1.7%, 21/1,230 to 11%, 65/603; p<0.001). M1UK was observed in 9 of 10 states, concentrated in Georgia (n = 41), Tennessee (n = 13), and New York (n = 13). Genomic cluster analysis indicated recent expansions.

EID Li Y, Rivers J, Mathis S, Li Z, Chochua S, Metcalf BJ, et al. Expansion of Invasive Group A Streptococcus M1UK Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021. Emerg Infect Dis. 2023;29(10):2116-2120. https://doi.org/10.3201/eid2910.230675
AMA Li Y, Rivers J, Mathis S, et al. Expansion of Invasive Group A Streptococcus M1UK Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021. Emerging Infectious Diseases. 2023;29(10):2116-2120. doi:10.3201/eid2910.230675.
APA Li, Y., Rivers, J., Mathis, S., Li, Z., Chochua, S., Metcalf, B. J....McGee, L. (2023). Expansion of Invasive Group A Streptococcus M1UK Lineage in Active Bacterial Core Surveillance, United States, 2019‒2021. Emerging Infectious Diseases, 29(10), 2116-2120. https://doi.org/10.3201/eid2910.230675.

Estimate of COVID-19 Deaths, China, December 2022–February 2023 [PDF - 401 KB - 4 pages]
Z. Du et al.

China announced a slight easing of its zero-COVID rules on November 11, 2022, and then a major relaxation on December 7, 2022. We estimate that the ensuing wave of SARS-CoV-2 infections caused 1.41 million deaths in China during December 2022–February 2023, substantially higher than that reported through official channels.

EID Du Z, Wang Y, Bai Y, Wang L, Cowling B, Meyers L. Estimate of COVID-19 Deaths, China, December 2022–February 2023. Emerg Infect Dis. 2023;29(10):2121-2124. https://doi.org/10.3201/eid2910.230585
AMA Du Z, Wang Y, Bai Y, et al. Estimate of COVID-19 Deaths, China, December 2022–February 2023. Emerging Infectious Diseases. 2023;29(10):2121-2124. doi:10.3201/eid2910.230585.
APA Du, Z., Wang, Y., Bai, Y., Wang, L., Cowling, B., & Meyers, L. (2023). Estimate of COVID-19 Deaths, China, December 2022–February 2023. Emerging Infectious Diseases, 29(10), 2121-2124. https://doi.org/10.3201/eid2910.230585.

Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023 [PDF - 1.23 MB - 5 pages]
A. Hoxha et al.

The 2022–2023 mpox outbreak predominantly affected adult men; 1.3% of reported cases were in children and adolescents <18 years of age. Analysis of global surveillance data showed 1 hospital intensive care unit admission and 0 deaths in that age group. Transmission routes and clinical manifestations varied across age subgroups.

EID Hoxha A, Kerr SM, Laurenson-Schafer H, Sklenovská N, Mirembe B, Nezu I, et al. Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023. Emerg Infect Dis. 2023;29(10):2125-2129. https://doi.org/10.3201/eid2910.230516
AMA Hoxha A, Kerr SM, Laurenson-Schafer H, et al. Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023. Emerging Infectious Diseases. 2023;29(10):2125-2129. doi:10.3201/eid2910.230516.
APA Hoxha, A., Kerr, S. M., Laurenson-Schafer, H., Sklenovská, N., Mirembe, B., Nezu, I....Pavlin, B. I. (2023). Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023. Emerging Infectious Diseases, 29(10), 2125-2129. https://doi.org/10.3201/eid2910.230516.

Outbreak of Sexually Transmitted Nongroupable Neisseria meningitidis–Associated Urethritis, Vietnam [PDF - 1.98 MB - 6 pages]
H. Nguyen et al.

We report on an outbreak of nongroupable Neisseria meningitidis–associated urethritis, primarily among men who have sex with men in southern Vietnam. Nearly 50% of N. meningitidis isolates were resistant to ciprofloxacin. This emerging pathogen should be considered in the differential diagnosis and management of urethritis.

EID Nguyen H, Phan TV, Tran H, Vu T, Pham N, Nguyen T, et al. Outbreak of Sexually Transmitted Nongroupable Neisseria meningitidis–Associated Urethritis, Vietnam. Emerg Infect Dis. 2023;29(10):2130-2134. https://doi.org/10.3201/eid2910.221596
AMA Nguyen H, Phan TV, Tran H, et al. Outbreak of Sexually Transmitted Nongroupable Neisseria meningitidis–Associated Urethritis, Vietnam. Emerging Infectious Diseases. 2023;29(10):2130-2134. doi:10.3201/eid2910.221596.
APA Nguyen, H., Phan, T. V., Tran, H., Vu, T., Pham, N., Nguyen, T....Nguyen, T. V. (2023). Outbreak of Sexually Transmitted Nongroupable Neisseria meningitidis–Associated Urethritis, Vietnam. Emerging Infectious Diseases, 29(10), 2130-2134. https://doi.org/10.3201/eid2910.221596.

Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020–2022 [PDF - 1.53 MB - 5 pages]
P. Zhang et al.

We report the clonal spread and evolution of high-risk Pseudomonas aeruginosa sequence type 463 co-producing KPC-2 and AFM-1 carbapenemases isolated from hospital patients in China during 2020–2022. Those strains pose a substantial public health threat and surveillance and stricter infection-control measures are essential to prevent further infections.

EID Zhang P, Wu W, Wang N, Feng H, Wang J, Wang F, et al. Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020–2022. Emerg Infect Dis. 2023;29(10):2136-2140. https://doi.org/10.3201/eid2910.230509
AMA Zhang P, Wu W, Wang N, et al. Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020–2022. Emerging Infectious Diseases. 2023;29(10):2136-2140. doi:10.3201/eid2910.230509.
APA Zhang, P., Wu, W., Wang, N., Feng, H., Wang, J., Wang, F....Qu, T. (2023). Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020–2022. Emerging Infectious Diseases, 29(10), 2136-2140. https://doi.org/10.3201/eid2910.230509.

Seafood-Associated Outbreak of ctx-Negative Vibrio mimicus Causing Cholera-Like Illness, Florida, USA [PDF - 719 KB - 4 pages]
M. T. Alam et al.

Vibrio mimicus caused a seafood-associated outbreak in Florida, USA, in which 4 of 6 case-patients were hospitalized; 1 required intensive care for severe diarrhea. Strains were ctx-negative but carried genes for other virulence determinants (hemolysin, proteases, and types I–IV and VI secretion systems). Cholera toxin–negative bacterial strains can cause cholera-like disease.

EID Alam MT, Stern SR, Frison D, Taylor K, Tagliamonte MS, Nazmus S, et al. Seafood-Associated Outbreak of ctx-Negative Vibrio mimicus Causing Cholera-Like Illness, Florida, USA. Emerg Infect Dis. 2023;29(10):2141-2144. https://doi.org/10.3201/eid2910.230486
AMA Alam MT, Stern SR, Frison D, et al. Seafood-Associated Outbreak of ctx-Negative Vibrio mimicus Causing Cholera-Like Illness, Florida, USA. Emerging Infectious Diseases. 2023;29(10):2141-2144. doi:10.3201/eid2910.230486.
APA Alam, M. T., Stern, S. R., Frison, D., Taylor, K., Tagliamonte, M. S., Nazmus, S....Morris, J. (2023). Seafood-Associated Outbreak of ctx-Negative Vibrio mimicus Causing Cholera-Like Illness, Florida, USA. Emerging Infectious Diseases, 29(10), 2141-2144. https://doi.org/10.3201/eid2910.230486.

Influenza A(H5N1) Virus Infections in 2 Free-Ranging Black Bears (Ursus americanus), Quebec, Canada [PDF - 2.99 MB - 5 pages]
B. T. Jakobek et al.

Wholly Eurasian highly pathogenic avian influenza H5N1 clade 2.3.4.4b virus was isolated from 2 free-ranging black bears with meningoencephalitis in Quebec, Canada. We found that isolates from both animals had the D701N mutation in the polymerase basic 2 gene, previously known to promote adaptation of H5N1 viruses to mammal hosts.

EID Jakobek BT, Berhane Y, Nadeau M, Embury-Hyatt C, Lung O, Xu W, et al. Influenza A(H5N1) Virus Infections in 2 Free-Ranging Black Bears (Ursus americanus), Quebec, Canada. Emerg Infect Dis. 2023;29(10):2145-2149. https://doi.org/10.3201/eid2910.230548
AMA Jakobek BT, Berhane Y, Nadeau M, et al. Influenza A(H5N1) Virus Infections in 2 Free-Ranging Black Bears (Ursus americanus), Quebec, Canada. Emerging Infectious Diseases. 2023;29(10):2145-2149. doi:10.3201/eid2910.230548.
APA Jakobek, B. T., Berhane, Y., Nadeau, M., Embury-Hyatt, C., Lung, O., Xu, W....Lair, S. (2023). Influenza A(H5N1) Virus Infections in 2 Free-Ranging Black Bears (Ursus americanus), Quebec, Canada. Emerging Infectious Diseases, 29(10), 2145-2149. https://doi.org/10.3201/eid2910.230548.

Limited Outbreak of Highly Pathogenic Influenza A(H5N1) in Herring Gull Colony, Canada, 2022 [PDF - 1.35 MB - 5 pages]
L. U. Taylor et al.

In summer 2022, highly pathogenic influenza A(H5N1) virus reached the herring gull (Larus argentatus subspecies smithsonianus) breeding colony on Kent Island, New Brunswick, Canada. Real-time monitoring revealed a self-limiting outbreak with low mortality. Proactive seabird surveillance is crucial for monitoring such limited outbreaks, protecting seabirds, and tracing zoonotic transmission routes.

EID Taylor LU, Ronconi RA, Spina HA, Jones M, Ogbunugafor C, Ayala AJ. Limited Outbreak of Highly Pathogenic Influenza A(H5N1) in Herring Gull Colony, Canada, 2022. Emerg Infect Dis. 2023;29(10):2150-2154. https://doi.org/10.3201/eid2910.230536
AMA Taylor LU, Ronconi RA, Spina HA, et al. Limited Outbreak of Highly Pathogenic Influenza A(H5N1) in Herring Gull Colony, Canada, 2022. Emerging Infectious Diseases. 2023;29(10):2150-2154. doi:10.3201/eid2910.230536.
APA Taylor, L. U., Ronconi, R. A., Spina, H. A., Jones, M., Ogbunugafor, C., & Ayala, A. J. (2023). Limited Outbreak of Highly Pathogenic Influenza A(H5N1) in Herring Gull Colony, Canada, 2022. Emerging Infectious Diseases, 29(10), 2150-2154. https://doi.org/10.3201/eid2910.230536.

Antimicrobial Resistance in Slaughterhouses, Kenya [PDF - 967 KB - 4 pages]
K. A. Hamilton et al.

Slaughterhouses are hotspots for the transmission of antimicrobial-resistant pathogens. We conducted stakeholder discussions on antimicrobial-resistant pathogens within the slaughterhouse setting. Butchers were described as powerful stakeholders; challenges included limited funding and staff, inadequate infrastructure, and limited laboratory capacity. Slaughterhouse workers understood that their work increased their risk for exposure.

EID Hamilton KA, Njoroge SM, Momanyi K, Murungi MK, Odinga CO, Bor N, et al. Antimicrobial Resistance in Slaughterhouses, Kenya. Emerg Infect Dis. 2023;29(10):2155-2158. https://doi.org/10.3201/eid2910.230017
AMA Hamilton KA, Njoroge SM, Momanyi K, et al. Antimicrobial Resistance in Slaughterhouses, Kenya. Emerging Infectious Diseases. 2023;29(10):2155-2158. doi:10.3201/eid2910.230017.
APA Hamilton, K. A., Njoroge, S. M., Momanyi, K., Murungi, M. K., Odinga, C. O., Bor, N....Falzon, L. C. (2023). Antimicrobial Resistance in Slaughterhouses, Kenya. Emerging Infectious Diseases, 29(10), 2155-2158. https://doi.org/10.3201/eid2910.230017.

Human-to-Human Transmission of Andes Virus Modeled in Syrian Hamsters [PDF - 2.72 MB - 5 pages]
S. A. Riesle-Sbarbaro et al.

Several occurrences of human-to-human transmission of Andes virus, an etiological agent of hantavirus cardiopulmonary syndrome, are documented. Syrian hamsters consistently model human hantavirus cardiopulmonary syndrome, yet neither transmission nor shedding has been investigated. We demonstrate horizontal virus transmission and show that Andes virus is shed efficiently from both inoculated and contact-infected hamsters.

EID Riesle-Sbarbaro SA, Kirchoff N, Hansen-Kant K, Stern A, Kurth A, Prescott JB. Human-to-Human Transmission of Andes Virus Modeled in Syrian Hamsters. Emerg Infect Dis. 2023;29(10):2159-2163. https://doi.org/10.3201/eid2910.230544
AMA Riesle-Sbarbaro SA, Kirchoff N, Hansen-Kant K, et al. Human-to-Human Transmission of Andes Virus Modeled in Syrian Hamsters. Emerging Infectious Diseases. 2023;29(10):2159-2163. doi:10.3201/eid2910.230544.
APA Riesle-Sbarbaro, S. A., Kirchoff, N., Hansen-Kant, K., Stern, A., Kurth, A., & Prescott, J. B. (2023). Human-to-Human Transmission of Andes Virus Modeled in Syrian Hamsters. Emerging Infectious Diseases, 29(10), 2159-2163. https://doi.org/10.3201/eid2910.230544.

Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve [PDF - 588 KB - 3 pages]
G. Ramakrishnan et al.

We report a case of Mycoplasma genitalium endocarditis in a prosthetic heart valve of a woman who sought care in Switzerland for acute aortic valve dysfunction 3 years after valve replacement. This unusual manifestation of infection with this bacterium was diagnosed using broad-range PCR despite suspicion of a mechanical disinsertion.

EID Ramakrishnan G, Kronig I, Gaïa N, Lazarevic V, Schrenzel J. Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve. Emerg Infect Dis. 2023;29(10):2164-2166. https://doi.org/10.3201/eid2910.221639
AMA Ramakrishnan G, Kronig I, Gaïa N, et al. Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve. Emerging Infectious Diseases. 2023;29(10):2164-2166. doi:10.3201/eid2910.221639.
APA Ramakrishnan, G., Kronig, I., Gaïa, N., Lazarevic, V., & Schrenzel, J. (2023). Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve. Emerging Infectious Diseases, 29(10), 2164-2166. https://doi.org/10.3201/eid2910.221639.

Angiostrongylus cantonensis Infection in Brown Rats (Rattus norvegicus), Atlanta, Georgia, USA, 2019–2022 [PDF - 1.66 MB - 4 pages]
N. L. Gottdenker et al.

Rat lungworm (Angiostrongylus cantonensis), a zoonotic parasite invasive to the United States, causes eosinophilic meningoencephalitis. A. cantonensis harbors in rat reservoir hosts and is transmitted through gastropods and other paratenic hosts. We discuss the public health relevance of autochthonous A. cantonensis cases in brown rats (Rattus norvegicus) in Atlanta, Georgia, USA.

EID Gottdenker NL, Nascimento Ramos R, Hakimi H, McHale B, Rivera S, Miller BM, et al. Angiostrongylus cantonensis Infection in Brown Rats (Rattus norvegicus), Atlanta, Georgia, USA, 2019–2022. Emerg Infect Dis. 2023;29(10):2167-2170. https://doi.org/10.3201/eid2910.230706
AMA Gottdenker NL, Nascimento Ramos R, Hakimi H, et al. Angiostrongylus cantonensis Infection in Brown Rats (Rattus norvegicus), Atlanta, Georgia, USA, 2019–2022. Emerging Infectious Diseases. 2023;29(10):2167-2170. doi:10.3201/eid2910.230706.
APA Gottdenker, N. L., Nascimento Ramos, R., Hakimi, H., McHale, B., Rivera, S., Miller, B. M....Verocai, G. G. (2023). Angiostrongylus cantonensis Infection in Brown Rats (Rattus norvegicus), Atlanta, Georgia, USA, 2019–2022. Emerging Infectious Diseases, 29(10), 2167-2170. https://doi.org/10.3201/eid2910.230706.
Research Letters

Bacillus subtilis Bacteremia from Gastrointestinal Perforation after Natto Ingestion, Japan [PDF - 305 KB - 2 pages]
T. Hashimoto et al.

We report a case of Bacillus subtilis variant natto bacteremia from a gastrointestinal perforation in a patient who ingested natto. Genotypic methods showed the bacteria in a blood sample and the ingested natto were the same strains. Older or immunocompromised patients could be at risk for bacteremia from ingesting natto.

EID Hashimoto T, Yahiro T, Khan S, Kimitsuki K, Hiramatsu K, Nishizono A. Bacillus subtilis Bacteremia from Gastrointestinal Perforation after Natto Ingestion, Japan. Emerg Infect Dis. 2023;29(10):2171-2172. https://doi.org/10.3201/eid2910.230084
AMA Hashimoto T, Yahiro T, Khan S, et al. Bacillus subtilis Bacteremia from Gastrointestinal Perforation after Natto Ingestion, Japan. Emerging Infectious Diseases. 2023;29(10):2171-2172. doi:10.3201/eid2910.230084.
APA Hashimoto, T., Yahiro, T., Khan, S., Kimitsuki, K., Hiramatsu, K., & Nishizono, A. (2023). Bacillus subtilis Bacteremia from Gastrointestinal Perforation after Natto Ingestion, Japan. Emerging Infectious Diseases, 29(10), 2171-2172. https://doi.org/10.3201/eid2910.230084.

Borrelia bavariensis in Questing Ixodes ricinus Ticks, United Kingdom [PDF - 545 KB - 3 pages]
G. Plahe et al.

We detected Borrelia bavariensis in Ixodes ricinus ticks collected near 2 towns in the United Kingdom. Human B. bavariensis infections have not been reported previously in the country, underscoring the value of tick surveillance to warn of emerging human disease. B. bavariensis should be considered in patients with suspected neuroborreliosis.

EID Plahe G, Hall JL, Johnson D, Gilbert L, Birtles RJ. Borrelia bavariensis in Questing Ixodes ricinus Ticks, United Kingdom. Emerg Infect Dis. 2023;29(10):2173-2175. https://doi.org/10.3201/eid2910.230907
AMA Plahe G, Hall JL, Johnson D, et al. Borrelia bavariensis in Questing Ixodes ricinus Ticks, United Kingdom. Emerging Infectious Diseases. 2023;29(10):2173-2175. doi:10.3201/eid2910.230907.
APA Plahe, G., Hall, J. L., Johnson, D., Gilbert, L., & Birtles, R. J. (2023). Borrelia bavariensis in Questing Ixodes ricinus Ticks, United Kingdom. Emerging Infectious Diseases, 29(10), 2173-2175. https://doi.org/10.3201/eid2910.230907.

Emergence of Novel Type C Botulism Strain in Household Outbreak, Japan [PDF - 377 KB - 3 pages]
R. Maeda et al.

In 2021, an outbreak of food poisoning caused by Clostridium botulinum type C occurred in Kumamoto, Japan. Analysis of the isolated strain revealed that it possessed the bont/C gene and was slightly different from the reference bont/C gene. The risk for human infection with this new toxin type may be low.

EID Maeda R, Mori M, Harada S, Izu I, Hirano T, Inoue Y, et al. Emergence of Novel Type C Botulism Strain in Household Outbreak, Japan. Emerg Infect Dis. 2023;29(10):2175-2177. https://doi.org/10.3201/eid2910.230433
AMA Maeda R, Mori M, Harada S, et al. Emergence of Novel Type C Botulism Strain in Household Outbreak, Japan. Emerging Infectious Diseases. 2023;29(10):2175-2177. doi:10.3201/eid2910.230433.
APA Maeda, R., Mori, M., Harada, S., Izu, I., Hirano, T., Inoue, Y....Koyama, H. (2023). Emergence of Novel Type C Botulism Strain in Household Outbreak, Japan. Emerging Infectious Diseases, 29(10), 2175-2177. https://doi.org/10.3201/eid2910.230433.

Plasmodium knowlesi Infection in Traveler Returning to Canada from the Philippines, 2023 [PDF - 544 KB - 3 pages]
C. Lo et al.

A 55-year-old man sought treatment for an uncomplicated febrile illness after returning to Canada from the Philippines. A suspected diagnosis of Plasmodium knowlesi infection was confirmed by PCR, and treatment with atovaquone/proguanil brought successful recovery. We review the evolving epidemiology of P. knowlesi malaria in the Philippines, specifically within Palawan Island.

EID Lo C, Plewes K, Sharma S, Low A, Su LD, Belga S, et al. Plasmodium knowlesi Infection in Traveler Returning to Canada from the Philippines, 2023. Emerg Infect Dis. 2023;29(10):2177-2179. https://doi.org/10.3201/eid2910.230809
AMA Lo C, Plewes K, Sharma S, et al. Plasmodium knowlesi Infection in Traveler Returning to Canada from the Philippines, 2023. Emerging Infectious Diseases. 2023;29(10):2177-2179. doi:10.3201/eid2910.230809.
APA Lo, C., Plewes, K., Sharma, S., Low, A., Su, L. D., Belga, S....Hogan, C. A. (2023). Plasmodium knowlesi Infection in Traveler Returning to Canada from the Philippines, 2023. Emerging Infectious Diseases, 29(10), 2177-2179. https://doi.org/10.3201/eid2910.230809.

Reemergence of Cosmopolitan Genotype Dengue Virus Serotype 2, Southern Vietnam [PDF - 821 KB - 3 pages]
V. T. Tran et al.

We performed phylogenetic analysis on dengue virus serotype 2 Cosmopolitan genotype in Ho Chi Minh City, Vietnam. We document virus emergence, probable routes of introduction, and timeline of events. Our findings highlight the need for continuous, systematic genomic surveillance to manage outbreaks and forecast future epidemics.

EID Tran VT, Inward R, Gutierrez B, Nguyen NM, Nguyen PT, Rajendiran I, et al. Reemergence of Cosmopolitan Genotype Dengue Virus Serotype 2, Southern Vietnam. Emerg Infect Dis. 2023;29(10):2180-2182. https://doi.org/10.3201/eid2910.230529
AMA Tran VT, Inward R, Gutierrez B, et al. Reemergence of Cosmopolitan Genotype Dengue Virus Serotype 2, Southern Vietnam. Emerging Infectious Diseases. 2023;29(10):2180-2182. doi:10.3201/eid2910.230529.
APA Tran, V. T., Inward, R., Gutierrez, B., Nguyen, N. M., Nguyen, P. T., Rajendiran, I....Yacoub, S. (2023). Reemergence of Cosmopolitan Genotype Dengue Virus Serotype 2, Southern Vietnam. Emerging Infectious Diseases, 29(10), 2180-2182. https://doi.org/10.3201/eid2910.230529.
Books and Media

Parasites: The Inside Story [PDF - 345 KB - 1 page]
R. H. Hussein
EID Hussein RH. Parasites: The Inside Story. Emerg Infect Dis. 2023;29(10):2183. https://doi.org/10.3201/eid2910.230235
AMA Hussein RH. Parasites: The Inside Story. Emerging Infectious Diseases. 2023;29(10):2183. doi:10.3201/eid2910.230235.
APA Hussein, R. H. (2023). Parasites: The Inside Story. Emerging Infectious Diseases, 29(10), 2183. https://doi.org/10.3201/eid2910.230235.
Online Reports

One Health Approach to Globalizing, Accelerating, and Focusing Amphibian and Reptile Disease Research—Reflections and Opinions from the First Global Amphibian and Reptile Disease Conference [PDF - 682 KB - 7 pages]
M. J. Gray et al.

The world’s reptiles and amphibians are experiencing dramatic and ongoing losses in biodiversity, changes that can have substantial effects on ecosystems and human health. In 2022, the first Global Amphibian and Reptile Disease Conference was held, using One Health as a guiding principle. The conference showcased knowledge on numerous reptile and amphibian pathogens from several standpoints, including epidemiology, host immune defenses, wild population effects, and mitigation. The conference also provided field experts the opportunity to discuss and identify the most urgent herpetofaunal disease research directions necessary to address current and future threats to reptile and amphibian biodiversity.

EID Gray MJ, Ossiboff RJ, Berger L, Bletz MC, Carter E, DeMarchi JA, et al. One Health Approach to Globalizing, Accelerating, and Focusing Amphibian and Reptile Disease Research—Reflections and Opinions from the First Global Amphibian and Reptile Disease Conference. Emerg Infect Dis. 2023;29(10):1-7. https://doi.org/10.3201/eid2910.221899
AMA Gray MJ, Ossiboff RJ, Berger L, et al. One Health Approach to Globalizing, Accelerating, and Focusing Amphibian and Reptile Disease Research—Reflections and Opinions from the First Global Amphibian and Reptile Disease Conference. Emerging Infectious Diseases. 2023;29(10):1-7. doi:10.3201/eid2910.221899.
APA Gray, M. J., Ossiboff, R. J., Berger, L., Bletz, M. C., Carter, E., DeMarchi, J. A....Wilber, M. Q. (2023). One Health Approach to Globalizing, Accelerating, and Focusing Amphibian and Reptile Disease Research—Reflections and Opinions from the First Global Amphibian and Reptile Disease Conference. Emerging Infectious Diseases, 29(10), 1-7. https://doi.org/10.3201/eid2910.221899.
About the Cover

“Living People Who Breathe and Feel and Suffer and Love” [PDF - 1.46 MB - 2 pages]
B. Breedlove
EID Breedlove B. “Living People Who Breathe and Feel and Suffer and Love”. Emerg Infect Dis. 2023;29(10):2184-2185. https://doi.org/10.3201/eid2910.ac2910
AMA Breedlove B. “Living People Who Breathe and Feel and Suffer and Love”. Emerging Infectious Diseases. 2023;29(10):2184-2185. doi:10.3201/eid2910.ac2910.
APA Breedlove, B. (2023). “Living People Who Breathe and Feel and Suffer and Love”. Emerging Infectious Diseases, 29(10), 2184-2185. https://doi.org/10.3201/eid2910.ac2910.
Page created: September 20, 2023
Page updated: November 28, 2023
Page reviewed: November 28, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external